AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04482738 — intervention group
Intervention type: OTHER
Intervention: High-calorie meal
Description: Intake of a high-calorie meal (2500-3000 calories) within 15 minutes.
Study NCT03703674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GCSF
Description: Granulocyte-colony stimulating factors (G-CSF)
Study NCT03703674 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GCSF
Description: Granulocyte-colony stimulating factors (G-CSF)
Study NCT01383252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Water infusion in lieu of air insufflation
Description: Air pump is turned off, water is infused using a peristaltic pump to aid colonoscope insertion until the cecum is reached. Air pockets and dirty water are suctioned before clean water is infused (exchange) to facilitate scope insertion.
Study NCT01383252 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Air method
Description: Conventional air method with minimal insufflation of air to aid scope insertion until the cecum is reached. Water in aliquots will be used for irrigation and cleansing.
Study NCT02652559 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous measurements of PCO2
Description: PCO2 will be measured transcutaneously with an ear lobe sensor before initiation of NIV, and during the initiation period (SenTec DM®, Software V-STATS 4.0; SenTec AG; Therwil, Switzerland)
Study NCT02652559 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous measurements of PCO2
Description: PCO2 will be measured transcutaneously with an ear lobe sensor before initiation of NIV, and during the initiation period (SenTec DM®, Software V-STATS 4.0; SenTec AG; Therwil, Switzerland)
Study NCT02652559 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Description: Telemonitoring will be used to send data from the transcutaneous measurements, data from the EMG measurements and data from the ventilator from home to the hospital.
Study NCT02652559 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMG
Description: Surface EMG of the respiratory muscles will be used to monit patients in both groups as a surrogate marker of respiratory muscle unloading and to detect PVA during NIV
Study NCT02652559 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EMG
Description: Surface EMG of the respiratory muscles will be used to monit patients in both groups as a surrogate marker of respiratory muscle unloading and to detect PVA during NIV
Study NCT02652559 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home initiation of NIV
Description: The primary aim of the study is to compare home and inhospital initiation of NIV
Study NCT02652559 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Inhospital initiation of NIV
Description: The primary aim of the study is to compare home and inhospital initiation of NIV
Study NCT00482482 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: psychoeducation
Description: on weekly basis for 8 weeks
Study NCT00482482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: on weekly basis for 8 weeks
Study NCT03894761 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Night Pain in Patients with Rotator Cuff Syndrome
Description: The pain severity was evaluated using a 10 cm visual analogue scale , where 0 represented no pain, while 10 represented unbearable pain.At evaluation, the average of the pain during night for the last one week were inquired.
Study NCT04474054 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Catheter ablation to treat paroxysmal atrial fibrillation
Description: A pulmonary vein isolation will be performed using catheter ablation
Study NCT03004404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 730357
Description: BI 730357 film-coated tablet
Study NCT02103114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-thrombin III
Description: Intraoperatively- (correcting to 100%) according to the following formula:~Units required = ((100%- baseline ATIII level\*%) X body weight)/1.4~* expressed as a % normal level based on functional ATIII assay
Study NCT02103114 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline placebo
Study NCT02046512 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: 1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis
Study NCT02509078 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisatracurium Besylate
Description: Patients randomized to the early neuromuscular blockade arm will receive a cisatracurium besylate bolus of 15 mg, followed by a continuous infusion of 37.5 mg/hour for 48 hours. Patients randomized to the control arm will receive no protocol specified neuromuscular blockade.
Study NCT00675077 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Far Infrared Radiation
Description: Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
Study NCT06178718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNP-2092
Description: The drug will be administered once in each group.
Study NCT02046512 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill
Study NCT03883464 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: Restriction in postoperative fat diet
Study NCT01617122 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacteriophage OX174
Description: Give first dose of bacteriophage (2 x 109 PFU/kg body weight (0.02 ml/kg)) at visit one. Obtain labs prior to vaccine, 15 minutes, 1 week, 2 weeks, and 4 weeks after vaccine. 6 weeks after 1st vaccine, obtain blood, give 2nd dose of bacteriophage, obtain labs 15 minutes, 1 week, 2 weeks, and 4 weeks after vaccine. Selected patients may receive a tertiary vaccine.
Study NCT04636762 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Thoracic Radiation Dose: 3Gy, QD, total dose: 30-45Gy; Particpants with brain metastases：metastatic lesions≤3:whole brain radiotherapy with local simultaneous PGTV:50Gy/10F；metastatic lesions>3:whole brain radiotherapy PTV:30Gy/10F.
Study NCT02016378 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Bias retraining
Description: Participants will view pictures of drug (e.g., alcohol) and non-drug stimuli (e.g., soft drinks) on a computer. Participants will then use the computer to make the drug pictures smaller and the non-drug pictures larger.
Study NCT02016378 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham retraining
Description: Participants will view pictures of drug and non-drug related stimuli on a computer. Participants will then use the computer to make the pictures larger or smaller based on the tilt of the picture (slightly to the left or right), but without regard to the content of the picture.
Study NCT03157245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DOPPLER ULTRASOUND
Description: MESURE OF THE PRESENCE OR NOT OF A CATHETER RELATED VEIN THROMBOSIS
Study NCT05210075 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful with your Baby program
Description: The training Mindful with your baby consists of eight weekly 2-h sessions, plus a follow-up session 8 weeks later. The first and the fifth sessions are with the mothers only. The rest of the sessions are with both mothers and babies present. The sessions are finished by explaining the new home practices. Home practice consists of reading handouts about mindfulness and mindful parenting for mothers with a baby, formal and informal meditation practice.
Study NCT03758495 — intervention group
Intervention type: OTHER
Intervention: Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)
Description: The investigators will use these techniques combined with attention tests, memory tests, and clinical interviews to explore connections between these measures and activity in the brain in patients with a diagnosis of schizophrenia, major depressive disorder, and healthy controls.
Study NCT00478205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aricept (donepezil SR 23 mg)
Description: Patients will receive study medication orally, once daily, for 24 weeks according to a double-dummy design:~23 mg donepezil SR concurrently with placebo identical in appearance to the 10 mg donepezil IR formulation.
Study NCT00478205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aricept (donepezil IR 10 mg)
Description: Patients will receive study medication orally, once daily, for 24 weeks according to a double-dummy design:~10 mg donepezil IR concurrently with placebo identical in appearance to the 23 mg donepezil SR formulation.
Study NCT01132469 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Submucosal Dissection
Description: 5-years follow-up after Endoscopic Submucosal Dissection
Study NCT02850042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupation-based practice (OBP)
Study NCT02850042 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Modified-constraint induced therapy (m-CIT)
Study NCT03214445 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sealing margins with flow composite
Description: Seal the margin of restoration with Composite flow with nanofiller
Study NCT03214445 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sealing margins with seal
Description: Seal the margin of restoration with sealant without filler
Study NCT00696488 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil 0.5%
Description: Subjects will apply the smallest amount of study medication possible that is just sufficient to cover all of the affected areas daily to AK lesions
Study NCT03451708 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OKS
Description: Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.
Study NCT04467047 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stromal Cells infusion
Description: Intravenous 1\*10E6 MSCs/kg body weight Mesenchymal Stromal Cells infusion
Study NCT06178718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The Placebo will be administered once in each group.
Study NCT06178718 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The Placebo will be administered once in each group.
Study NCT03828890 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Screening eye exam using Optos technology
Description: Retinal imaging using Optos technology to identify Diabetic Retinopathy
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Description: Induction therapy. Group 1 and 2 study therapy regimens include induction with alemtuzumab, administered as a single intravenous dose intra-operatively over a period of 2 hours.
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alemtuzumab
Description: Induction therapy. Group 1 and 2 study therapy regimens include induction with alemtuzumab, administered as a single intravenous dose intra-operatively over a period of 2 hours.
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MMF
Description: All treatment groups (e.g., Group 1, 2 and 3): Administered at a target dose of 1000 mg by mouth twice daily beginning on the day of surgery or post operative day 1 and adjusted as clinically warranted.~Note: Myfortic® (mycophenolate sodium) may be used as a replacement for MMF, at a dose of 720 mg taken by mouth twice daily.
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MMF
Description: All treatment groups (e.g., Group 1, 2 and 3): Administered at a target dose of 1000 mg by mouth twice daily beginning on the day of surgery or post operative day 1 and adjusted as clinically warranted.~Note: Myfortic® (mycophenolate sodium) may be used as a replacement for MMF, at a dose of 720 mg taken by mouth twice daily.
Study NCT01436305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Basiliximab
Description: Induction therapy. Group 3 study therapy regimen includes induction with basiliximab, administered in two doses: 1 dose administered within 2 hours prior to transplantation surgery and the 2nd dose 4 days after transplantation (unless held due to contraindication\[s\])
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Short-term Tac
Description: Short-term (3 months)
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tacrolimus
Description: maintenance
Study NCT01436305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Belatacept
Description: maintenance
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: All study treatment groups: administration started on the day of transplant and tapered over a 4 day course.
Study NCT01436305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylprednisolone
Description: All study treatment groups: administration started on the day of transplant and tapered over a 4 day course.
Study NCT01012947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Usual Care
Description: Usual care participants in the group A received no additional services.
Study NCT01012947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Telephone, Bimonth
Description: Participants in the group B received bimonthly telephonic care management based on manual.
Study NCT01012947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Telephone, Month
Description: Participants in the group C received monthly the same telephonic care management and educational materials as those in the group B.
Study NCT01012947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Visit, Bimonth
Description: Participants in the group D received health educator-initiated visit counseling bimonthly.
Study NCT01012947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Counseling Visit, Reward
Description: Participants in the group E received health educator-initiated visit counseling bimonthly and reward.
Study NCT03299348 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AgingPLUS
Description: The program consists of 2-hour meetings for a total of 4 weeks (total of 8 hours) and discusses (a) how negative views on aging and negative age stereotypes undermine adults' health-promoting behaviors; (b) how adults can take control of their own aging; and (c) how personal goals can be achieved through more effective goal planning and action plans.
Study NCT03299348 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Active Control Group
Description: The program consists of 2-hour meetings for a total of 4 weeks (total of 8 hours) and discusses (a) four major health conditions that affect the lives of many middle-aged and older adults (e.g., cardiovascular disease, cancer, type 2 diabetes; clinical depression); and (b) how these conditions can be managed successfully.
Study NCT04802304 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beyond Bias Treatment
Description: The intervention has three components: 1) a summit that includes impactful stories told to and by family planning providers that highlight the consequences of provider bias, 2) a forum for continued communication between providers, and 3) a rewards program where clinics in which providers exhibit less biased client interactions or who have improved the most towards this end will be rewarded with social recognition and a ceremony.
Study NCT01160237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PandemrixTM
Description: One dose intramuscular injection
Study NCT01160237 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FluarixTM/ Influsplit SSW® 2010/2011
Description: One dose intramuscular injection
Study NCT01160237 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FluarixTM/ Influsplit SSW® 2010/2011
Description: One dose intramuscular injection
Study NCT01566097 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smoking Cessation Decision Aids
Description: The decision aids were developed through: 1) literature review; 2) qualitative interviews with Korean smokers from various backgrounds; 3) expert opinions. They were in the form of short educational videos (flash), displayed by Apple's iPad.~The decision aids contained the followings, in proper Korean social and cultural context:~1. Information on the risk of continued smoking and benefits of cessation~2. Messages that address common misbeliefs regarding smoking cessation services and medications~3. Information on possible smoking cessation options, their efficacy, side effects, costs, etc.~The choices given in the decisions aid were:~1. Behavioral only~2. Nicotine replacement therapy~3. Bupropion~4. Varenicline
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Single oral dose at D-8
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Moxifloxacin
Description: Single oral dose at D-8
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single oral dose at D-1
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single oral dose at D-1
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanifibranor
Description: Single daily oral dose during 14 days
Study NCT03866369 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single daily oral dose during 14 days
Study NCT01084226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rye-2008
Study NCT01084226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Rye-2008
Study NCT02830529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MAD DASH
Description: Participants were taught mindfulness meditation including body scan, loving kindness meditation and breathing exercises. The diet education component included lecture on reading labels, low cost healthy meal preparation, and dietary consultation regarding personal strengths and self-identified areas of improvement.
Study NCT02830529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DASH diet education
Description: The diet education component included lecture on reading labels, low cost healthy meal preparation, and dietary consultation regarding personal strengths and self-identified areas of improvement.
Study NCT00855413 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Darunavir
Description: 800 mg orally once daily
Study NCT00855413 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ritonavir
Description: 100 mg orally once daily
Study NCT00855413 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Etravirine
Description: 200 mg orally twice daily, although patients may choose to take ETR 400 mg QD to have a simpler all QD regimen
Study NCT00825305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Abbreviated Zagreb 2-1-1 schedule
Description: Subjects received the abbreviated Zagreb 2-1-1 schedule in a safety-lead-in phase.
Study NCT00825305 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Essen 1-1-1-1-1 schedule
Description: Subjects received the standard Essen regimen.
Study NCT03382769 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cochlear implantation
Description: Unilateral implantation with a commercially approved Nucleus cochlear implant
Study NCT03382769 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cochlear implantation
Description: Unilateral implantation with a commercially approved Nucleus cochlear implant
Study NCT03124654 — intervention group
Intervention type: BEHAVIORAL
Intervention: Education
Description: Patients will receive several questionnaires to fill in. Knowledge about NOACs will be assessed with a newly developped questionnaire and an educational program will be dispensed while analysing the answers (reactive educational program).
Study NCT02872389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: Anesthesia was maintained with sevoflurane in patients undergoing arthroscopic knee surgery under general anesthesia. End-tidal concentration of sevoflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period.
Study NCT02872389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desflurane
Description: Anesthesia was maintained with desflurane in patients undergoing arthroscopic knee surgery under general anesthesia. End-tidal concentration of desflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period.
Study NCT00729638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAD001
Description: Dose levels will change: Taken orally either every other day for the first three weeks of each cycle or taken every day for the first three weeks of each cycle.
Study NCT00729638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenalidomide
Description: Dose level will vary: taken orally 30-60 minutes after taking RAD001 every day for the first three weeks of each cycle.